Publications:27
- Home
- Profiles
Ahmed Khattab, MD
- About Me
- Clinical Focus
- Research
- Publications
- Industry Relationships
About Me
Language
Position
About Me
Language
Position
Clinical Focus
- Autoimmune Hypothyroidism
- Congenital Adrenal Hyperplasia
- Congenital Hypothyroidism
- Delayed Puberty
- Disorders of the Adrenal, Ovary and Testis
- Growth Failure
- Growth Hormone Deficiency
- Hypogonadotropic Hypogonadism
- Obesity
Show More
- Autoimmune Hypothyroidism
- Congenital Adrenal Hyperplasia
- Congenital Hypothyroidism
- Delayed Puberty
- Disorders of the Adrenal, Ovary and Testis
- Growth Failure
- Growth Hormone Deficiency
- Hypogonadotropic Hypogonadism
- Obesity
- Precocious Puberty
Research
Publications
Selected Publications
- Atypical genitalia in the newborn. Sowmya Krishnan, Jonathan Meyer, Ahmed Khattab.
- Corticotropin releasing factor-1 receptor antagonism associated with favorable outcomes of male reproductive health biochemical parameters. Ahmed Khattab, R. Will Charlton. Frontiers in Endocrinology
- Controversies surrounding female athletes with differences in sexual development. Ahmed Khattab, Ian Marshall, Sally Radovick. Journal of Clinical Investigation
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Khattab has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Khattab has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.